Reviva Pharmaceuticals (RVPH) plans a public offering of shares and warrants, using the proceeds to fund research and development, support working capital, and cover general corporate purposes.
The transaction is subject to market conditions, and "there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms," the company said late Thursday in a statement.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.